|
Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis.
|
Jan 2019
|
Crit Rev Oncol Hematol
|
myelodysplastic syndromes (MDS)
|
|
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study
|
Sep 2015
|
Lancet Oncol.
|
myelodysplastic syndromes (MDS)
|
|
Prognostic value of telomere attrition in patients with aplastic anemia.
|
May 2013
|
Leuk Res
|
aplastic anemia
|
|
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
|
Mar 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age
|
May 2023
|
Blood Reviews
|
myelodysplastic syndromes (MDS)
|
|
Prognostication in Myelodysplastic Syndromes: Beyond the International Prognostic Scoring System (IPSS)
|
Apr 2013
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints
|
Jul 2017
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
|
Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia
|
Jun 2014
|
Am J Hematol
|
aplastic anemia
|
|
Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes
|
Jan 2017
|
Vox Sang
|
myelodysplastic syndromes (MDS)
|
|
Proposed score for survival of patients with myelodysplastic syndromes.
|
Sep 2013
|
Eur J Clin Invest
|
myelodysplastic syndromes (MDS)
|
